Clinical Trial Update: Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Pycnogenol for lymphedema of the arm in breast cancer survivors has completed, sponsored by the National Center for Compleme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphedema

Drugs mentioned

• Pycnogenol (French maritime pine bark extract (Pinus pinaster bark extract))

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Lymphedema, Breast | Phase 2 | Status: COMPLETED